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Astrocytes, the most prominent glial cell type in the brain, send specialized processes
called endfeet, around blood vessels and express a large molecular repertoire regulating
the cerebrovascular system physiology. One of the most striking properties of astrocyte
endfeet is their enrichment in gap junction proteins Connexin 43 and 30 (Cx43 and Cx30)
allowing in particular for direct intercellular trafficking of ions and small signaling molecules
through perivascular astroglial networks. In this study, we addressed the specific role of
Cx30 at the gliovascular interface. Using an inactivation mouse model for Cx30 (Cx30∆/∆;
∆ means deleted allele) we showed that absence of Cx30 does not affect blood-brain
barrier (BBB) organization and permeability. However, it results in the cerebrovascular
fraction, in a strong upregulation of Sgcg encoding γ-Sarcoglycan (γ-SG), a member
of the Dystrophin-associated protein complex (DAPC) connecting cytoskeleton and the
extracellular matrix. The same molecular event occurs in Cx30T5M/T5M mutated mice,
where Cx30 channels are closed, demonstrating that Sgcg regulation relied on Cx30
channel functions. We further characterized the expression of other Sarcoglycan complex
(SGC) molecules in the cerebrovascular system and showed the presence of α-, β-, δ-,
γ-, ε- and ζ- SG, as well as Sarcospan. Their expression was however not modified in
Cx30∆/∆. These results suggest that a full SGC might be present in the cerebrovascular
system, and that expression of one of its member, γ-SG, depends on Cx30 channels.
As described in skeletal muscles, the SGC may contribute to membrane stabilization and
signal transduction in the cerebrovascular system, which may therefore be regulated by
Cx30 channel-mediated functions.
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INTRODUCTION
Astrocytes, the major glial cells in the brain, represent a
rather unique example of multifunctional cells in the central
nervous system (CNS), being in tight vicinity with neurons
and blood vessels, and regulating both neuronal and vascular
functions. In particular, astrocytes make intimate contacts with
the cerebrovascular system elaborating the so-called gliovascular
unit, sheathing blood vessels with specialized processes termed
endfeet (Mathiisen et al., 2010). Astrocytes perform a range
of vascular regulatory activities, coordinating blood flow with
neuronal activity (Petzold and Murthy, 2011) and regulating
metabolite transfer to neurons (Bélanger et al., 2011). They
also contribute to the blood-brain barrier (BBB) that creates a
specific microenvironment vital to the CNS functions, regulating
its integrity (Abbott et al., 2006) and its immune quiescence
(Alvarez et al., 2011; Argaw et al., 2012; Urich et al., 2012; Jensen
et al., 2013). A typical feature of astrocytes is their high level of
Connexin (Cx) expression, with two major subunits, Cx43 and
Cx30. Cxs assemble by 6 in connexons, which when inserted in the
plasma membrane, dock together to form gap junction channels
allowing direct astrocyte-to-astrocyte exchange of ions and small
signaling molecules up to 1–1.2 kDa. Connexons can also stay in a
hemichannel (Hc) conformation and mediate the direct exchange
of molecules between the intra- and extracellular milieu (Chever
et al., 2014a; Sáez and Leybaert, 2014). Finally, Cxs mediate
channel-independent functions, such as cell-cell adhesion and
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signalization (Elias et al., 2007, 2010; Zhou and Jiang, 2014). To
date, Cx30 and Cx43 have been shown to contribute both or
individually to several aspects of the brain physiology, such as
energy metabolite trafficking (Rouach et al., 2008), neurogenesis
(Kunze et al., 2009), myelin maintenance (Lutz et al., 2009;
May et al., 2013) and control of synaptic activity (Theis et al.,
2003; Dallérac et al., 2013; Chever et al., 2014b; Pannasch et al.,
2014).
Interestingly, astroglial Cxs are highly concentrated in
perivascular endfeet where they form large gap junction plaques
(Simard et al., 2003; Ezan et al., 2012), allowing the elaboration
of electrical and chemical astroglial networks around the brain
endothelium (Rouach et al., 2008). This molecular and structural
organization led us to hypothesize that astroglial Cxs may
participate to the regulation of vascular functions. Accordingly,
deletion of both Cx43 and Cx30, which uncouples astrocytes
(Rouach et al., 2008), has been shown to weaken BBB integrity
(Ezan et al., 2012). Here, we addressed the specific contribution
of astroglial Cx30 to the BBB organization.
MATERIALS AND METHODS
MICE
Animals were kept in pathogen free conditions. Mice of either
sex were used in this study except for the transcriptome analysis
and in situ perfusion experiments for which only males were
selected. Cx30∆/∆ (∆ means deleted allele) are ubiquitously
deleted for Cx30 (Boulay et al., 2013). Cx30T5M/T5M mice carry
a point-mutated form of Cx30 in place of Cx30, resulting in
the replacement of a threonine at position 5 by a methionine
(Schütz et al., 2010). Cx30T5M/T5M mice were maintained on
a pure C57BL6 genetic background. Cx30∆/∆ and Cx30+/+
(wild-type (WT) mice) had a C57BL6/Balbc genetic background
for the transcriptome study and were pure C57BL6 for other
experiments.
STUDY APPROVAL
Experiments and techniques reported here complied with the
ethical rules of the French agency for animal experimentation
and with the IMTCE (Institut Médicament Toxicologie Chimie
Environnement) animal ethics committee (Université Paris
Descartes) (agreement number 86-23).
ISOLATION OF BRAIN VESSELS, RNA PREPARATION, cDNA LIBRARIES
AND RNA SEQUENCING
Brain vessels from 3-month-old Cx30∆/∆ mice (Boulay et al.,
2013) and control Cx30+/+ mice were isolated from whole
brains as previously described (Yousif et al., 2007). mRNAs
were subsequently purified and sequenced. Purified vessels from
3 mice of each group were pooled. Total RNA was extracted
using the Rneasy Lipid tissue kit (Qiagen). Messenger (polyA+)
RNAs were purified from 1 µg of total RNA using oligo (dT).
Libraries were prepared using the strand non-specific RNA-Seq
library preparation TruSeq RNA Sample Prep Kits v2 (Illumina).
Libraries were multiplexed on one single flowcell lane and
subjected to 50 base pair (bp) single read sequencing on a HiSeq
2000 device. A mean of 56 ± 27 million passing illumina quality
filter reads was obtained for each samples.
The whole RNA-Seq data analysis was done using the
Eoulsan software version 1.1.6 (Jourdren et al., 2012) with the
following parameters. Before mapping, polyN read tails were
trimmed, reads ≤11 bases were removed, and reads with quality
mean ≤12 were discarded. Reads were then aligned against
the Mus musculus genome (mm10 genome assembly from
UCSC) using the Bowtie mapper (version 0.12.7) (Langmead
et al., 2009) using the—best and –k 2 parameters. Alignments
from reads matching more than once on the reference genome
were removed. To compute gene expression, Mus musculus
GFF3 genome annotation from UCSC (mm10) was used. All
overlapping regions between alignments and referenced exons
were counted. Data normalization and differential analysis
was performed using the DESeq package version 1.6.10
(Anders and Huber, 2010). RNA sequencing data are available
at: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=qtyrsa
kstzerxmv&acc=GSE59148.
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION (RT-PCR)
AND QUANTITATIVE POLYMERASE CHAIN REACTION (qPCR)
Reverse transcription was performed from RNA extracted from
purified brain vessels (300 ng) or dissected hippocampus
and cortex (1 µg) using the Rneasy kit (Qiagen) and
Supercripts II (Life Technologies). Polymerase chain reaction
(PCR) was performed on 1 µL of RT reaction using Taq
polymerase (Qiagen) and the following primers: Sgcg (γ-SG)
forward 5′-TCACCGAGGGCACTCACATA-3′; Sgcg reverse
5′-CCAACCACAACGTCCTGCT3′; Sgca (α-SG) forward 5′-
GCCGAGTCCCTCTTCCTATT-3′; Sgca reverse 5′-CCAGAG
ACACATTGCACCAG-3′; Sgcb (β-SG) forward 5′-AGCAT
GGAGTTCCACGAGAG-3′; Sgcb reverse 5′-GCTGGTGATGG
AGGTCTTGT-3′; Sgcd (δ-SG) forward GTCAGAGCAGA
CCCCTTCAA ; Sgcd reverse 5′-GATCCACGAGGCAGTCTAGC-
3′; Sgce (ε-SG) forward 5′-TCCATCACAGCTCGATTCAG-3′;
Sgce reverse 5′-TCTGAGTCTGGTGTGGCAAG-3′; Sgcz (ζ-SG)
forward 5′-GAAAGAAATTCATTCCCGAAAGG-3′; Sgcz reverse
5′-GAATCAGGAAAGGTGAAGGCCAA-3′; Sarcospan forward
5′-AGAGGACTTGCTGCTCTTGC-3′; Sarcospan reverse 5′-
CCTTTCGGTGTTCACCAAGT-3′. Sgcg qPCR was conducted
using SYBR Green PCR master kit (Applied Biosystems). qPCR
cycling conditions were 50◦C for 2 min, 95◦C 10 min, and 40
cycles of 95◦C for 15 s and 60◦C for 1 min. All experiments
were performed in triplicate on an LC480 Roche Light cycler.
The relative abundance of amplified cDNA was calculated
as 2−∆Ct, where ∆Ct (change in cycle threshold) equals Ct
in Cx30∆/∆ minus Ct in Cx30+/+. Results are expressed as
means of (2−∆Ct tested cDNA)/(2−∆Ct RNA18s values). RNA18s
forward 5′-TTGAAAATCCGGGGGAGAG-3′; RNA18s reverse
5′-ACATTGTTCCAACATGCCAG-3′. RT-PCR cycling conditions
were 95◦C for 3 min, and 35 cycles of 95◦C for 30 s, 60◦C for
30 s and 72◦C for 1 min. Negative controls for RT-PCR and
qPCR were done on RT reactions performed without reverse
transcriptase.
IN SITU BRAIN PERFUSION
Mice were anesthetized with ketamine-xylazine (140-8 mg/kg,
i.p.) and a polyethylene catheter was inserted into the carotids.
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The heart was cut and the perfusion was started immediately
(flow rate: 2.5 mL/min) to obtain a complete substitution of
the blood by the artificial perfusion fluid, a Krebs bicarbonate-
buffered physiological saline (mM)(128 NaCl, 24 NaHCO3, 4.2
KCl, 2.4 NaH2PO4, 1.5 CaCl2, 0.9 MgCl2, 9 D-glucose) containing
also [14C]-sucrose (0.3 µCi/mL) (Perkin Elmer Life Sciences,
Courtaboeuf, France) as a vascular and integrity marker, gassed
with 95% O2/5% CO2 for pH control (7.4) and warmed to
37◦C. Sucrose (glucose-fructose) is a low molecular weight
disaccharide compound. Being hydrophilic, it does not bind
to plasma proteins. Moreover, in contrast to the very specific
monosaccharide (e.g., glucose) transporters, sucrose has no
dedicated transporter in mammals and thus exhibits negligible
BBB/cellular crossing (Takasato et al., 1984). Perfusion was
terminated after 120 s by decapitating the mouse. The whole
brain was removed from the skull and dissected out on a freezer
pack. Tissue and two aliquots of perfusion fluid were placed
in tared vials and weighed, digested with Solvable® (Perkin
Elmer) and mixed with Ultima gold XR® (Perkin Elmer) for
14C counting (Tri-Carb®, Perkin Elmer). In some experiments,
human serum albumin (40 g/L) (Vialebex, Paris, France) was
added in the perfusion fluid to increase its viscosity and
then the hydrostatic pressure (∼180 mmHg) according to the
Poiseuille’s law (Ezan et al., 2012). The brain vascular volume
(Vv) (µL/g) was calculated using the distribution of [14C]-
sucrose: Vv = Xv/Cv where Xv (dpm/g) is the [14C]-sucrose
measured in the right hemisphere and Cv (dpm/µL) is the
concentration of [14C]-sucrose in the perfusion fluid (Dagenais
et al., 2000).
IMMUNOFLUORESCENCE ON PURIFIED BRAIN VESSELS
Purified brain vessels prepared as described by (Yousif et al.,
2007) were fixed by immersion in PBS/PFA 4% for 20 min at
room temperature, rinsed three times in PBS, and immersed in
the blocking solution (PBS/NGS 5%/Triton 0.25%) for 1 h at
room temperature. They were then incubated with monoclonal
anti Gfap (clone GA5, Sigma) (dilution: 1/500), SMA (clone
1A4, Sigma) (dilution: 1/500) in the blocking solution 12 h
a 4◦C, rinsed three times in PBS, incubated 2 h at room
temperature with secondary antibodies Alexa-conjugated goat
anti-mouse IgG (Life technology; A11029/A21424), rinsed three
times in PBS, and mounted on glass slides in FluormountG for
fluorescent revelation. Fluorescence was imaged on a SP5 confocal
microscope (Leica).
WESTERN BLOT
Purified brain vessels or whole cortex and hippocampus were
homogenized in PBS containing 2% SDS and 1x EDTA-free
Complete Protease Inhibitor (Roche), sonicated three times at
10 Hz (Vibra cell VCX130) and centrifuged 20 min at 10000 g
at 4◦C. Supernatants were boiled in 5x Laemmli loading buffer.
Protein content was measured using the Pierce 660 nm protein
assay reagent (Thermo scientific). Equal amounts of proteins
were separated by denaturing electrophoresis in 4–12% or
3–8% (for anti-ZO-1) NuPAGE gradient gel (Invitrogen) and
electrotransfered to nitrocellulose membranes. Membranes
were analyzed using the following primary antibodies:
rabbit anti-Occludin (Invitrogen) (1:500); mouse anti-ZO-
1 (Invitrogen) (1:500); mouse anti-Cx43 (BD Biosciences)
(1:500); rabbit anti-Aquaporin-4 (Aqp4) (Sigma, St Louis,
MO, USA) (1:500); rabbit anti-Claudin-5 (Invitrogen) (1:500);
mouse anti-β-Dystroglycan (β-DG) (Novocastra, Newcastle,
UK) (1:200); monoclonal anti γ-Sarcoglycan (γ-SG) (Leica)
(1:100); horseradish-peroxidase-conjugated (HRP) anti-GAPDH
(1:5000); mouse anti-tubulin (Sigma) (1:2000). Secondary
antibodies used were HRP-conjugated goat anti-mouse and anti-
rabbit antibodies (Amersham) (dilution 1:2000). HRP activity
was visualized by enhanced chemiluminescence (ECL) using
Western Lightning plus enhanced chemoluminescence system
(Perkin Elmer). Chemoluminescence imaging was performed on
a LAS4000 (Fujifilm). Tubulin or GAPDH expression was used as
a loading reference.
ELECTRON MICROSCOPY
Mice were anesthetized with Ketamine-Xylazine (140-8 mg/kg,
i.p.) and transcardially perfused with the fixative (2%
Paraformaldehyde, 3% Glutaraldehyde, 3 mM CaCl2 in 0.1
M Cacodylate Buffer pH 7.4) for 2 min at 10 mL/min and then
for 30 min at 2 mL/min. Brains were removed and left overnight
at 4◦C in the same fixative. Brain fragments (0.3 × 1 × 1 mm3)
were then postfixed first in 0.1 M Cacodylate Buffer pH 7.4
+ 1% OsO4 for 1 h at 4◦C and then in 1% aqueous Uranyl
Acetate for 2 h at RT. After dehydration in graded Ethanol,
followed by Propylene Oxyde, the fragments were embedded in
Epon. Ultrathin (80 nm) sections were prepared, stained in Lead
Citrate and photographed in a Jeol 100S transmission electron
microscope (Jeol, Croissy-sur-Seine, France) equipped with a 2k
× 2k Orius 830 CCD camera (Roper Scientific, Evry, France).
RESULTS
ABSENCE OF Cx30 DOES NOT PERTURB BBB INTEGRITY
In a recent study, we demonstrated that deletion of Cx43 and
Cx30, the two major astroglial Cxs, modifies endfeet architecture
and weakens BBB (Ezan et al., 2012). Here, we addressed the
specific contribution of Cx30 to BBB integrity in 3-month-old
Cx30-deleted mice (Cx30∆/∆) where Cx30 is ubiquitously deleted
(Boulay et al., 2013) compared to WT (Cx30+/+) mice. Western-
blot detection of endothelial tight junction (TJ) proteins ZO-1,
Claudin-5 and Occludin in 3-month-old Cx30∆/∆ and Cx30+/+
cortex and hippocampus revealed no difference (Figure 1A).
The same observation could be done also for Cx43, as well as
Aqp4 and β-DG, two molecules decreased in the brain of mice
deleted for both Cx30 and astroglial Cx43 (Ezan et al., 2012;
Figure 1A). We next measured the brain Vv of Cx30+/+ and
Cx30∆/∆ by in situ brain perfusion of [14C]-sucrose (Dagenais
et al., 2000; Ezan et al., 2012; Figure 1B). In this experiment,
[14C]-sucrose was used as a marker of the vascular space and
BBB integrity because it does not cross the BBB significantly
during short exposure (Takasato et al., 1984). The distribution
of [14C]-sucrose Vv was measured in the whole brain after 120
s of in situ brain perfusion of regular Krebs at 2.5 mL/min. No
statistical difference was noticed between Cx30+/+ and Cx30∆/∆
mice, indicating that BBB integrity was unchanged in absence
of Cx30. We next examined the mechanical resistance of the
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FIGURE 1 | Astroglial Cx30 is not required for BBB integrity.
(A) Western-blot of tight junction (TJ) proteins ZO-1, Claudin-5 and Occludin,
Connexin43, Aquaporin-4 (Aqp4) and β-Dystroglycan (β-DG) in 3-month-old
Cx30+/+ and Cx30∆/∆ cortex and hippocampus. GAPDH was used as the
loading control (n = 4). (B) BBB integrity in 3-month-old Cx30+/+ and Cx30∆/∆
mice was assessed by measuring the brain vascular volume (Vv in µL/g) by
in situ brain perfusion of [14C]-sucrose in normal intravascular pressure
(−Albumin; 120 mmHg) or increased shear stress and hydrostatic vascular
pressure (+Albumin, 180 mmHg). No Albumin: Cx30+/+, 15.6 ± 0.5 and
Cx30∆/∆, 18.8 ± 0.4 (n = 7); With Albumin: Cx30+/+, 18.2 ± 2.2 and
Cx30∆/∆, 18.6 ± 1.2 (n = 7). Data are means ± SEM. Kruskal-Wallis test
followed by a Dunn’s multiple comparisons test, p = 0.2 (ns).
BBB performing in situ brain perfusion in presence of human
serum albumin in the saline perfusion to increase shear stress
and hydrostatic vascular pressure (from 110 to 180 mmHg) (Ezan
et al., 2012; Figure 1B). However, even in these conditions, the
Vv in Cx30∆/∆ remained comparable to Cx30+/+ and to the Vv
recorded without albumin (Figure 1B). Thus albumin-mediated
shear stress and vascular pressure increase had no effect on
the BBB permeability, indicating no alteration of BBB integrity
in absence of Cx30. We finally addressed the ultrastructure
of the gliovascular unit in each segment of the vasculature
(proximal and distal arterioles, capillaries and veins) in 3-
month-old Cx30∆/∆ compared to Cx30+/+ mice (Figure 2). No
significant difference was found between Cx30∆/∆ and Cx30+/+
at the ultrastructural level: endothelial TJ were well formed and
extended from the vessel lumen to the basal lamina (BL) with
no apparent discontinuity, no accumulation of pinocytic vesicles
was observed; BL around capillaries was thin and regular except
in arterioles where it was occasionally enlarged by fragments
of amorphous elastic material; Astroglial perivascular endfeet
were in close contact with the BL and showed thin processes
with a dense intracellular content and no sign of swelling. In
arterioles, vascular smooth muscle cells (VSMCs) were normal
and separated from the astroglial endfeet by a regular BL, where
macrophages and fibrocytes were found. They showed frequent
junctional contacts with endothelial cells. Altogether, these results
demonstrate that neither the permeability of the BBB to plasmatic
compounds, nor the structure of the gliovascular unit, were
perturbed following the genetic inactivation of Cx30.
IMPAIRMENT OF Cx30 CHANNELS UPREGULATES THE EXPRESSION OF
γ-SARCOGLYCAN IN BRAIN VESSELS
To further address the role of Cx30 at the cerebrovascular
level, we analyzed the transcriptome of isolated brain vessels
purified from 3-month-old Cx30∆/∆ and control mice (Figure 3).
As previously described, this preparation contains endothelial
cells, VSMCs and pericytes (Yousif et al., 2007). We further
verified the absence of astrocytes in our vessel preparation
performing Gfap immunostaining on isolated brain vessels.
Only few remaining Gfap positive fibers could be detected at
the vascular surface but no copurified astrocyte cell bodies
(Figure 3A).1 Since Cx30∆/∆ mice were maintained on a mixed
C57BL6/Balbc genetic background, and background strongly
impacts gene transcription (Iacobas et al., 2012), two distinct
WT RNAs libraries, from C57BL6 and C57BL6/Balbc (Cx30+/+)
mice, were prepared. We then compared the Cx30∆/∆ and WT
transcriptomes and selected changes observed in Cx30∆/∆ brain
vessels whatever the genetic background. Genes with less than 50
reads and/or with fold change less than 2 were not considered.
Selected transcriptional variations were further validated by
qPCR on independent brain vessel preparations. Consistently
with the above data (Figure 1), transcription of junctional
molecules as well as pathways implicated in BBB integrity were
not modified in absence of Cx30. Among the transcriptional
events detected in the Cx30∆/∆ brain vascular transcriptome,
we confirmed the strong upregulation of Sgcg encoding γ-
SG, a member of the dystrophin-glycoprotein complex (DGC)
connecting cytoskeleton and the extracellular matrix (Ozawa
et al., 2005; Figure 3C). We next aimed to establish which Cx30
function was involved in the regulation of Sgcg. Indeed, Cx30
displays gap junction and Hc functions as well as channel-
independent functions (Qu et al., 2009; Pannasch et al., 2014). We
confirmed Sgcg upregulation in whole cortex and hippocampus
and analyzed its transcription level in Cx30T5M/T5M mice, in
1http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=qtyrsakstzerxmv&acc
=GSE59148 to see the data.
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FIGURE 2 | Ultrastructure of the gliovascular unit in absence of Cx30.
Representative images of the gliovascular unit ultrastructure in 3-month-old
Cx30+/+ (A,C,E,G) and Cx30∆/∆ (B,D,F,H) mice (n = 4) within a
post-capillary venule (A,B) a capillary (C,D) and an arteriole (E,F,G,H)
showing astroglial perivascular endfeet (a), endothelial cells (e) with TJs
(black arrowheads), vascular smooth muscle cells (VSMCs) (m) fibrocytes (f)
and pericytes (p). Fragments of amorphous elastic material in basal lamina
(white arrowheads) and junctional contacts between endothelial and
smooth muscle cells (white arrows) are found in arterioles. Scale bars
500 nm.
which the replacement of a threonine by a methionine at
position 5 of Cx30 leads to a defective Cx30 channel pore but
intact membrane targeting (Schütz et al., 2010; Figure 3C).
As observed in Cx30∆/∆, Sgcg was strongly upregulated in
Cx30T5M/T5M compared to Cx30+/+. We finally tested if the
transcriptional upregulation of Sgcg led to an increase in γ-
SG protein performing a Western-blot of proteins extracted
from brain vessels (Figures 3D,E). Consistently with qPCR
results, γ-SG was increased in Cx30∆/∆ and Cx30T5M/T5M
brain vessels. These results thus suggest that absence of Cx30
channels leads to the increase of γ-SG in the brain vessels and
that Sgcg transcription is regulated by astroglial Cx30 channel
functions.
THE SARCOGLYCAN COMPLEX IS EXPRESSED IN THE BRAIN VESSELS
The Sarcoglycan complex (SGC) is a multimeric transmembrane
protein assembly, which has been extensively studied in striated
muscle cells (Ozawa et al., 2005). It interacts with the DG and
is part of the Dystrophin-associated protein complex (DAPC),
bridging the extracellular matrix to the actin cytoskeleton and
ensuring membrane stability and force transduction during
muscle contraction (Constantin, 2014). In the brain, SG units
have been found in the membranes and the cytoplasm of
some large cortical neurons as well as in some astrocyte cell
bodies (Anastasi et al., 2012). However, the presence of a SGC
in the cerebrovascular system had never been documented.
Following the finding of a brain vascular γ-SG, we tested
if other units of the SGC were expressed performing RT-
PCR experiments in purified brain vessels. As shown in
Figure 4A, transcripts encoding all known SG units, α, β, δ,
ε, γ and ζ as well as Sarcospan were amplified. δ- and ζ-
SG amplification showed additional higher bands, which could
correspond to uncharacterized transcript isoforms (Figure 4A).
We next determined if SGC molecules were expressed in all
vessel types by repeating this RT-PCR study on brain vessels
separated by size (Yousif et al., 2007; Figure 4B). Interestingly,
δ- and ε-SG were expressed only in vessels with a diameter
>100µm (Figure 4B). Finally, our transcriptome analysis showed
that α, β, δ, ε, γ and ζ-SG and Sarcospan expression was not
changed in Cx30∆/∆ purified vessels (Figure 4C). Altogether,
our results suggest that the whole SGC might be present in
brain vessels, with δ- and ε-SG being specific to the largest
vessels.
DISCUSSION
Here, we addressed the role of Cx30, a gap junction protein
highly enriched in the astrocyte perivascular endfeet, in the brain
vascular physiology. In a previous study, we demonstrated that
deletion of Cx30 and Cx43 (DKO mice), the major astroglial
Cxs, led to astrocyte endfeet swelling and to a reduced BBB
resistance to shear stress (Ezan et al., 2012). None of these
effects were observed in Cx30∆/∆ mice. In addition, in agreement
with the absence of BBB leakage, gene expression of junctional
molecules and pathways implicated in BBB integrity were not
modified in the cerebrovascular fraction in absence of Cx30. In
particular, expression of β-DG and Aqp4, two major proteins
of the DAPC at gliovascular interface, which were decreased in
DKO mice, was not modified in Cx30∆/∆. Thus, astroglial Cx43,
whose expression was unchanged in Cx30∆/∆ mice, would be
sufficient to maintain the BBB integrity and the gliovascular unit
structure. However, Sgcg encoding γ-SG was highly upregulated
in Cx30∆/∆ mice. Thus, Cx43 is unable to compensate for
Frontiers in Cellular Neuroscience www.frontiersin.org February 2015 | Volume 9 | Article 9 | 5
Boulay et al. Cx30 regulates Sgcg expression at the blood-brain barrier
FIGURE 3 | Impairment of Cx30 channels upregulates the expression of
γ-Sarcoglycan in brain vessels. (A) Characterization of purified brain
vessels by Gfap and SMA (Smooth Muscle alpha-Actin) immunostaining.
(B) Upregulation of Sgcg in brain vessels purified from 3-month-old
Cx30∆/∆ compared to Cx30+/+ and C57BL6 control mice revealed by RNA
sequencing. Base mean indicates the number of reads, Fc indicates Fold
change. On the right, Validation of the RNAseq result by qPCR on RNAs
purified from brain vessels of Cx30∆/∆ relative to Cx30+/+ control mice.
Cx30+/+ value is set as 1. (C) qPCR analysis on 3-month-old Cx30+/+
compared to Cx30∆/∆ and Cx30T5M/T5M cortex and hippocampus. Cx30∆/∆,
5.0 ± 0.6 n = 4; Cx30T5M/T5M, 8.6 ± 1.4 n = 4; Cx30+/+, 1.0 ± 0.1 n = 3.
Data are presented as means ± SEM. Mann-Whitney two-tailed test.
Cx30+/+ vs. Cx30∆/∆ or Cx30T5M/T5M, ∗p = 0.05; Cx30∆/∆ vs. Cx30T5M/T5M
ns, p = 0.5. (D) Western-blot of γ-SG (30 kDa) in 3-month-old Cx30+/+,
Cx30∆/∆ and Cx30T5M/T5M purified brain vessels. Tubulin (50 kDa) was used
as the loading control. (E) Western blot quantifications. Cx30∆/∆, 4.7 ± 1
n = 5; Cx30T5M/T5M, 12.5 ± 4.9 n = 3; Cx30+/+, 1.0 ± 0.4 n = 6. Data are
presented as means ± SEM. Mann-Whitney two-tailed test. Cx30+/+ vs.
Cx30∆/∆, **p = 0.009; Cx30+/+ vs. Cx30T5M/T5M, *p = 0.02; Cx30∆/∆ vs.
Cx30T5M/T5M ns p = 0.07.
this upregulation, and Cx30 plays a specific role in the Sgcg
trancriptional control, which remains to be defined. Recent
data have unraveled an unexpected complexity and variety in
the Cx functions (Zhou and Jiang, 2014). Independently of
their channel functions (GJ and Hc), Cxs have been shown to
display adhesive (Elias et al., 2007, 2010), as well as signaling
functions (Scemes, 2008). Moreover, Cx30 interacts with actin,
tubulin (Qu et al., 2009) and was recently shown to control
astroglial morphology through channel-independent functions
(Pannasch et al., 2014). Here, Sgcg upregulation was also found
in Cx30T5M/T5M mice, where only Cx30 channel functions are
disrupted (Schütz et al., 2010). These results thus suggest
that the Cx30-mediated control of Sgcg transcription relies
specifically on its channel functions, either gap junction, Hc or
both.
γ-SG belongs to the SGC and interacts with β-DG within
the muscular DAPC, a transmembrane heteromeric complex
linking the cytoskeleton to the BL, crucial to the mechanical
signal transduction (Ozawa et al., 2005). In addition to its
bridging properties between the extracellular matrix and the
cytoskeleton, the DAPC has also been proposed to constitute a
putative cellular signaling complex by conferring the scaffold for
numerous signaling proteins and ion channels. Along this line,
it would influence calcium homeostasis and signaling (reviewed
by Constantin, 2014). For instance, the cysteine-rich domain
of Dystrophin may represent a functional Calmodulin-binding
domain modulating the recruitment of other Dystrophin-
associated proteins in a calcium-dependent manner. The
DAPC-calcium homeostasis regulation is also mediated by the
SGC. For instance, Sgcg deletion in mice has been shown to
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FIGURE 4 | Composition of the SG complex in brain vessels. (A) α, β, δ, ε,
γ and ζ-Sarcoglycan (SG) as well as Sarcospan were all amplified by RT-PCR
on brain vessels purified from 3-month-old control mice. (B) RT-PCR analysis
of the SG complex in brain vessels retained on a 100 µm filter (>100 µm in
diameter) or on a 20 µm filter (from 20 to 100 µm in diameter), base pair (bp).
(C) RNAseq analysis of α, β, δ, ε, γ and ζ-SG and Sarcospan in brain vessels
purified from 3-month-old Cx30∆/∆ compared to Cx30+/+ and C57BL6 control
mice. Base mean indicates the number of reads, Fc indicates Fold change.
induce the upregulation of Sorcin, a calcium-handling protein,
leading to disruption of the DAPC in muscles (Goldstein et al.,
2014). In the brain, DAPCs of various compositions have been
described at the level of specialized cellular contacts with the
extracellular matrix, in GABAergic synapses (Waite et al., 2012),
in the choroid plexus (Haenggi and Fritschy, 2006) and at
the BBB level in endothelial cells (Zaccaria et al., 2001; del
Zoppo and Milner, 2006; Haenggi and Fritschy, 2006), astrocyte
endfeet (Haenggi and Fritschy, 2006; Wolburg et al., 2009) and
VSMCs (North et al., 1993; Yousif et al., 2013). At the astrocyte
endfeet level, the DAPC was shown to anchor the water channel
Aqp4, which is critical to regulate ATP release and astrocyte-
cell volume, via Ca2+-dependent signalizations (Benfenati et al.,
2011; Thrane et al., 2011). Based on our RT-PCR study, we
demonstrated that all SG units as well as Sarcopan were present
at the vascular level in the brain, with a differential expression of
δ- and ε-SG in vessels with a diameter >100 µm. Unfortunately,
available antibodies against SGC proteins gave very weak signal
on sections as well as on isolated brain vessels precluding
us to determine their precise cellular and subcellular site of
expression. Nevertheless, recent transcriptomic studies showed
that none of the SGC molecules are expressed in astrocytes and
endothelial cells, except for Sgcb found moderately transcribed
in the endothelial cells and Sgce in astrocytes and endothelial
cells (Zhang et al., 2014), while pericytes would expressed only
Sgce encoding ε-SG (Daneman et al., 2010). Together, these
results combined with ours suggest that the SGC transcripts
could be mainly provided by the VSMCs, the only remaining
possible source in the purified brain vessels. Then, what could
be the functional consequences of the Sgcg upregulation in
Cx30∆/∆? Strong Sgcg overexpression in striated muscles has
been shown to result in plasma membrane destabilization and
muscular dystrophy with a severity varying from no damage to
lethal muscle wasting disorder depending on the level of γ-SG
(Zhu et al., 2001). It also led to the upregulation of Sgca and
Sgcb encoding α-SG and β-SG (Zhu et al., 2001). Here, Sgca
and Sgcb expression levels were not modified in Cx30∆/∆ and
BBB ultrastructure and permeability were not altered, suggesting
that the level of Sgcg expression was not sufficient to produce
the same SGC alteration. It may however modify DAPCs-Ca2+
signaling, membrane contractility and stabilization, affecting thus
the neurovascular coupling.
In summary, our study demonstrates that absence of Cx30, an
astroglial gap junction protein highly expressed at the vascular
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interface, does not modify BBB integrity and ultrastructure, but
induces the upregulation of Sgcg encoding γ-SG, a member
of SGC which composes the muscular DAPC connecting
cytoskeleton and the extracellular matrix. Furthermore, we
demonstrate that all known SG units are expressed in the
brain vessels suggesting the existence of a cerebrovascular SGC.
Further studies will have now to determine the precise subcellular
location of this cerebrovascular SGC as well as to address
the physiological consequences of the upregulation of γ-SG in
Cx30∆/∆ mice.
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